Inventor · disambiguated record
Sena Kim
Also filed as: KIM SENA
5 granted patents·6 pending applications·2 citations·filing 2009–2024
64Inventor score
Top patents by PatentIndex Score
11 records- 0183US11807628B2Benzodiazepine derivatives and uses thereofINTOCELL INC·Filed 2021·Granted Nov 7, 2023·1 cites·20 claims
- 0275US11084801B2Benzodiazepine derivatives and uses thereofINTOCELL INC·Filed 2019·Granted Aug 10, 2021·1 cites·10 claims
- 0370US2025121087A1Antibody-drug conjugates comprising anti-b7-h3 antibodiesINTOCELL INC·Filed 2024·Application pending·0 cites
- 0463US2025213712A1Antibody drug conjugates comprising camptothecin derivatives and uses thereofINTOCELL INC·Filed 2024·Application pending·0 cites
- 0559US12168060B2Antibody-drug conjugates comprising anti-B7-H3 antibodiesINTOCELL INC·Filed 2021·Granted Dec 17, 2024·0 cites·22 claims
- 0656US2023190939A1Antibody drug conjugates comprising toxins with polar groups and uses thereofINTOCELL INC·Filed 2022·Application pending·0 cites
- 0754US8945633B2Pharmaceutical composition for preventing and treating inflammatory diseases containing an ethyl acetate fraction of dried extract of Trachelospermi caulis as an active ingredient, and method for producing the fractionLEE JEONG MIN·Filed 2009·Granted Feb 3, 2015·0 cites·9 claims
- 0852US2024218326A1Novel neuronal cell line for measuring titer of neurotoxinHUGEL INC·Filed 2022·Application pending·0 cites
- 0946US12274898B2Substituted benzodiazepines as antibody-drug conjugatesINTOCELL INC·Filed 2019·Granted Apr 15, 2025·0 cites·19 claims
- 1046US2023039858A1Compositions and methods related to molecular conjugationINTOCELL INC·Filed 2020·Application pending·0 cites
- 1144US2022118104A1Compounds comprising cleavable linker and uses thereofINTOCELL INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sena Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →